The largest database of trusted experimental protocols

4 protocols using pd l2 apc

1

Immunophenotyping of Splenocytes by Flow Cytometry

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following Abs were used to stain splenocytes for flow cytometry: B220-BrilliantViolet(BV)605 (BioLegend), Ly5.2-AlexaFluor(AF)700, Ly5.1-PE-Cy7, GL7-APC, CD95-biotin, CCR6-biotin, CD38-FITC, CXCR4-PerCP-eFluor710, CD80-FITC, PD-L2-APC, and Y-Ae-biotin (all from eBioscience). Biotinylated Abs were detected with streptavidin-coupled BV421 (BioLegend). Additional reagents used for flow cytometry included PNA-FITC and NP-PE. Surface staining was carried out as described [29 (link)]. MitoTracker Red (Invitrogen), Annexin V-FITC (eBioscience) and SYTOX Red viability dye (Invitrogen) were used according to manufacturer’s instructions. Data were acquired on a LSRII flow cytometer (BD Biosciences) and analyzed using FlowJo software (Treestar, Inc.).
+ Open protocol
+ Expand
2

Multicolor Flow Cytometry Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
The cells were stained with fluorescent dye–conjugated antibodies for 30 min on ice and washed twice with PBS. After resuspending in PBS containing 2% FBS, the cells were analyzed by fluorescence-activated cell sorting (FACS Calibur; BD Biosciences, Franklin, NJ, USA). The following antibodies were used in the analysis: CD34-FITC, CD73-FITC, CD90-FITC, CD90-PE, human leukocyte antigen (HLA)-ABC-FITC, HLA-DR-FITC (eBioscience, San Diego, CA, USA); CD44-FITC, CD105-APC (BD Biosciences); CD45-FITC (BioLegend, San Diego, CA, USA). In the case of fresh tissues, CD73-FITC, CD90-PE, and CD105-APC were used for triple staining. Antibodies against PD-L1-PE and PD-L2-APC were purchased from eBioscience.
+ Open protocol
+ Expand
3

Monocyte phenotyping with cancer cell interaction

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human monocytes were cultured alone or with mf or three different CMFDA-labeled cancer cell lines (green; FITC channel) as mentioned above. After 48 hrs, cells were harvested, washed with PBS and incubated with 10 μl human IgG (10 mg/ml; Sigma-Aldrich, St. Louis, MO) for 10 min at 4°C to inhibit nonspecific binding through FcγRs and then incubated with marker-specific mAb conjugated with PDL2- APC (eBioscience, Cat No. 17-5888-42), VCAM1(Vascular cell adhesion molecule-1)-APC (Biolegend, Cat No. 305810), CD14-APC Cy7 (eBioscience, Cat No. 47-0149-42), CD45-Pacific blue (Biolegend, Cat No. 304022), CD206 (Mannose receptor)-Percp efluor 710 (eBioscience, Cat No. 46-2069-42), PDL1-PE-Cy7 or PDL1-APC (eBioscience, Cat No. 25-5983-42 and Cat No. 17-5983-41 respectively), or CD163-PE (eBioscience, Cat No. 12-1639-42), CD45-PE (eBioscience, Cat No. 12-9459-42) at saturating concentrations for 30 min at 4°C and washed twice with FACS medium. Monocyte cell populations (CD45+/CMFDA-) were then identified and gated to measure the expression of cell surface markers.
+ Open protocol
+ Expand
4

Phenotyping Leukemic Cells from AML Patients

Check if the same lab product or an alternative is used in the 5 most similar protocols
Primary cells from peripheral blood of AML patients with hyperleukocytosis were obtained by leukapheresis before therapy initiation. The leukapheretic products were diluted 10-fold in phosphate buffered saline (PBS), and the mononuclear cell fraction was separated using Histopaque-1077 (Sigma, #H8889). The cells were resuspended in RPMI 1640 medium with 10% fetal calf serum and with antibiotics (100 U/ml penicillin, 100 µg/ml streptomycin), and aliquots were used for analysis of surface markers by flow cytometry and for mRNA isolation.
The antibodies used were as follows: CD45-V450 (#560367), CD4-BUV395 (#564724), CD8-BUV395 (#563795), CD19-BUV737 (#564303), CD34-BV786 (#743534), and CD371-BB515 (#565926) from BD Biosciences; HLA-DR-FITC (#11-9952-42), TIM-3-APC (#17-3109-42), and PD-L2-APC (#17-5888-42) from eBioscience; CLIP-PE (sc-12725 PE) from Santa Cruz; PD-L1-PE (#1P-177-T100), CD47-FITC (#1F-225-T100), and CD38-PE (#1P-366-T100) from Exbio (Prague, Czech Republic). HLA class I antibody (Abcam, ab2217) was conjugated in house using the Lightning-Link Fluorescein Conjugation kit (#707-0010, Innova Biosciences).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!